Cheek Augmentation in Gender-Affirming Facial Surgery.

The cheek area is an important area in facial beauty. High cheekbones and full malar area is considered a desired feminine feature and therefore an essential component of gender-affirming facial surgery. The most common treatment options are injectable fillers, autologous fat grafting, and alloplastic cheek implants. Fillers are customizable and reversible and have minimal recovery but are not preferred because of need for maintenance and cost. Fat grafting has many desirable characteristics, such as abundance, customizability, biocompatibility, and relative low cost. However, evidence for its long-term longevity is lacking. Alloplastic implants are a reliable augmentation method but associated with implant related complications such as infection, migration, and visibility.

Correlating pre-operative vitamin D status with post-thyroidectomy hypocalcemia.

OBJECTIVE: To examine the relationship between pre-operative vitamin D status and post-thyroidectomy hypocalcemia. METHODS: Retrospective study examining 264 total and completion thyroidectomies conducted between 2007 and 2011. Subjects included had a recorded 25-hydroxyvitamin D (25[OH]D) level within 21 days prior to or 1 day following surgery, did not have a primary parathyroid gland disorder, and were not taking 1,25-dihydroxyvitamin D3 (calcitriol) prior to surgery. Some subjects were repleted with vitamin D pre-operatively if a low 25(OH)D level (typically below 20 ng/mL) was identified. Pre-operative 25(OH)D, concurrent neck dissection, integrity of parathyroid glands, final pathology, postoperative parathyroid hormone (PTH), calcium nadir and repletion, and length of stay were examined. RESULTS: The mean pre-operative 25(OH)D for all subjects was 25 ng/mL, and the overall rate of post-operative hypocalcemia was 37.5%. Lower pre-operative 25(OH)D did not predict postoperative hypocalcemia (P = .96); however, it did predict the need for postoperative 1,25-dihydroxyvitamin D3 administration (P = .01). Lower postoperative PTH levels (P = .001) were associated with postoperative hypocalcemia. CONCLUSION: Pre-operative 25(OH)D did not predict a postoperative decrease in serum calcium, although it did predict the need for 1,25-dihydroxyvitamin D3 therapy in hypocalcemic subjects. We recommend that 25(OH)D be assessed and, if indicated, repleted pre-operatively in patients undergoing total thyroidectomy.